United States - English - NLM (National Library of Medicine)

physicians total care, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), prednisolone acetate (unii: 8b2807733d) (prednisolone - unii:9phq9y1olm) - sulfacetamide sodium 100 mg in 1 ml - a steroid/anti-infective combination is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular antibacterial drug in this product is active against the following common bacterial eye pa

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - trimethobenzamide hydrochloride (unii: wdq5p1sx7q) (trimethobenzamide - unii:w2x096qy97) - tigan® is indicated for the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis. the injectable form of tigan® is contraindicated in pediatric patients and in patients with known hypersensitivity to trimethobenzamide.

United States - English - NLM (National Library of Medicine)

henry schein, inc - trimethobenzamide hydrochloride (unii: wdq5p1sx7q) (trimethobenzamide - unii:w2x096qy97) - tigan ® is indicated for the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis. the injectable form of tigan® is contraindicated in pediatric patients and in patients with known hypersensitivity to trimethobenzamide. the injectable form of tigan® is contraindicated in pediatric patients and in patients with known hypersensitivity to trimethobenzamide.

New Zealand - English - Medsafe (Medicines Safety Authority)

allergan new zealand ltd - prednisolone acetate 0.22% (10% overage); sulfacetamide sodium monohydrate 10.5% (5% overage) - eye ointment - active: prednisolone acetate 0.22% (10% overage) sulfacetamide sodium monohydrate 10.5% (5% overage) excipient: lanolin liquid paraffin phenylmercuric acetate white soft paraffin

Canada - English - Health Canada

bausch & lomb inc - prednisolone sodium phosphate - drops - 0.5% - prednisolone sodium phosphate 0.5% - corticosteroids

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - timolol maleate - solution - 0.25 g/100 ml - timolol maleate 0.25 g/100 ml

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - timolol maleate - solution - 0.5 g/100 ml - timolol maleate 0.5 g/100 ml

Ireland - English - HPRA (Health Products Regulatory Authority)

chauvin pharmaceuticals limited - carteolol hydrochloride - eye drops prolonged rel. - 1 %w/v

Ireland - English - HPRA (Health Products Regulatory Authority)

chauvin pharmaceuticals limited - carteolol hydrochloride - eye drops prolonged rel. - 2 %w/v

Canada - English - Health Canada

allergan inc - sulfacetamide sodium; prednisolone acetate - ointment - 10%; 0.2% - sulfacetamide sodium 10%; prednisolone acetate 0.2% - sulfonamides